• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSULET CORPORATION OMNIPOD INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSULET CORPORATION OMNIPOD INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN Back to Search Results
Model Number 19191
Device Problem Insufficient Information (3190)
Patient Problems Hemorrhage/Bleeding (1888); Hyperglycemia (1905)
Event Date 12/29/2022
Event Type  malfunction  
Event Description
It was reported the patient's blood glucose rose to 350 mg/dl.The patient reported bleeding from the insertion site after wearing the pod for a couple of hours.As treatment, a new pod was applied.
 
Manufacturer Narrative
The pod was received with no evidence of blood on the device.Investigation results found no evidence of any damage or manufacturing deficiencies that would cause bleeding, bruising, or swelling at the infusion site.The exact cause of the reported swelling could not be determined.The device was received with the soft cannula deployed.Corrosion was observed on the pcb assembly, all three batteries, and the catch beam.Due to the corrosion, the bottom and middle battery voltages were measured to be lower than expected.Fluid path testing found a tear on the unexposed portion of the soft cannula which resulted in an internal leak.This leak prevented the proper delivery of insulin.Lot release records were reviewed and the product lot met all acceptance criteria.Specifically, a pod is paired to a pdm and put through simulated use testing including confirming the blue soft cannula is inspected for any damage.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNIPOD INSULIN MANAGEMENT SYSTEM
Type of Device
PUMP, INFUSION, INSULIN
Manufacturer (Section D)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer (Section G)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer Contact
michael spears
100 nagog park
acton, MA 01720
9786007000
MDR Report Key16708129
MDR Text Key312974124
Report Number3004464228-2023-09210
Device Sequence Number1
Product Code LZG
UDI-Device Identifier20385081120033
UDI-Public(01)20385081120033(11)211028(17)230428(10)L50286
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K211575
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 02/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/10/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/28/2023
Device Model Number19191
Device Catalogue NumberZXP425
Device Lot NumberL50286
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/24/2023
Date Manufacturer Received04/04/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/28/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Age27 YR
Patient SexMale
-
-